Summit Therapeutics Change in Accounts Payable 2015-2025 | SMMT
Summit Therapeutics change in accounts payable for the twelve months ending March 31, 2025 was $0.004B, a 62.86% decline year-over-year.
- Summit Therapeutics annual change in accounts payable for 2024 was $0.002B, a 10.96% decline from 2023.
- Summit Therapeutics annual change in accounts payable for 2023 was $0.002B, a 154.77% decline from 2022.
- Summit Therapeutics annual change in accounts payable for 2022 was $-0.004B, a 141.5% increase from 2021.